Go Pro

Chill Brands Group (CHLL) Competitors

Chill Brands Group logo
GBX 2.05 -0.15 (-6.82%)
As of 06:45 AM Eastern

CHLL vs. HELD, HLN, HIK, INDV, and HCM

Should you buy Chill Brands Group stock or one of its competitors? MarketBeat compares Chill Brands Group with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Chill Brands Group include Hellenic Dynamics (HELD), Haleon (HLN), Hikma Pharmaceuticals (HIK), Indivior (INDV), and HUTCHMED (HCM). These companies are all part of the "drug manufacturers - specialty & generic" industry.

How does Chill Brands Group compare to Hellenic Dynamics?

Chill Brands Group (LON:CHLL) and Hellenic Dynamics (LON:HELD) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, profitability, dividends, institutional ownership, earnings, analyst recommendations, valuation and risk.

Hellenic Dynamics' return on equity of -364.21% beat Chill Brands Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Chill Brands GroupN/A -2,802.21% -44.64%
Hellenic Dynamics N/A -364.21%N/A

1.5% of Chill Brands Group shares are held by institutional investors. Comparatively, 0.1% of Hellenic Dynamics shares are held by institutional investors. 10.3% of Chill Brands Group shares are held by company insiders. Comparatively, 72.9% of Hellenic Dynamics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Chill Brands Group has higher revenue and earnings than Hellenic Dynamics. Chill Brands Group is trading at a lower price-to-earnings ratio than Hellenic Dynamics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Chill Brands Group£305.70K3.51-£3.64M-£6.50N/A
Hellenic DynamicsN/AN/A-£5.22M-£3.55N/A

In the previous week, Chill Brands Group's average media sentiment score of 0.00 equaled Hellenic Dynamics'average media sentiment score.

Company Overall Sentiment
Chill Brands Group Neutral
Hellenic Dynamics Neutral

Summary

Hellenic Dynamics beats Chill Brands Group on 5 of the 8 factors compared between the two stocks.

How does Chill Brands Group compare to Haleon?

Chill Brands Group (LON:CHLL) and Haleon (LON:HLN) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, analyst recommendations, valuation, institutional ownership, profitability, media sentiment and earnings.

Chill Brands Group has a beta of 0.99, suggesting that its share price is 1% less volatile than the broader market. Comparatively, Haleon has a beta of 0.242, suggesting that its share price is 76% less volatile than the broader market.

In the previous week, Haleon had 3 more articles in the media than Chill Brands Group. MarketBeat recorded 3 mentions for Haleon and 0 mentions for Chill Brands Group. Haleon's average media sentiment score of 1.15 beat Chill Brands Group's score of 0.00 indicating that Haleon is being referred to more favorably in the news media.

Company Overall Sentiment
Chill Brands Group Neutral
Haleon Positive

Haleon has a consensus target price of GBX 393.67, suggesting a potential upside of 5.68%. Given Haleon's stronger consensus rating and higher possible upside, analysts clearly believe Haleon is more favorable than Chill Brands Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Chill Brands Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Haleon
2 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.17

Haleon has higher revenue and earnings than Chill Brands Group. Chill Brands Group is trading at a lower price-to-earnings ratio than Haleon, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Chill Brands Group£305.70K3.51-£3.64M-£6.50N/A
Haleon£11.03B2.97£1.07B£18.5020.14

Haleon has a net margin of 15.11% compared to Chill Brands Group's net margin of 0.00%. Haleon's return on equity of 10.30% beat Chill Brands Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Chill Brands GroupN/A -2,802.21% -44.64%
Haleon 15.11%10.30%4.45%

1.5% of Chill Brands Group shares are owned by institutional investors. Comparatively, 45.2% of Haleon shares are owned by institutional investors. 10.3% of Chill Brands Group shares are owned by insiders. Comparatively, 0.0% of Haleon shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Haleon beats Chill Brands Group on 13 of the 16 factors compared between the two stocks.

How does Chill Brands Group compare to Hikma Pharmaceuticals?

Hikma Pharmaceuticals (LON:HIK) and Chill Brands Group (LON:CHLL) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, earnings, media sentiment, profitability, analyst recommendations, institutional ownership, valuation and dividends.

In the previous week, Hikma Pharmaceuticals had 2 more articles in the media than Chill Brands Group. MarketBeat recorded 2 mentions for Hikma Pharmaceuticals and 0 mentions for Chill Brands Group. Hikma Pharmaceuticals' average media sentiment score of 0.75 beat Chill Brands Group's score of 0.00 indicating that Hikma Pharmaceuticals is being referred to more favorably in the media.

Company Overall Sentiment
Hikma Pharmaceuticals Positive
Chill Brands Group Neutral

Hikma Pharmaceuticals presently has a consensus target price of GBX 1,687, indicating a potential upside of 8.64%. Given Hikma Pharmaceuticals' stronger consensus rating and higher possible upside, equities research analysts plainly believe Hikma Pharmaceuticals is more favorable than Chill Brands Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hikma Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
3.00
Chill Brands Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Hikma Pharmaceuticals has a beta of 0.654, indicating that its share price is 35% less volatile than the broader market. Comparatively, Chill Brands Group has a beta of 0.99, indicating that its share price is 1% less volatile than the broader market.

63.6% of Hikma Pharmaceuticals shares are owned by institutional investors. Comparatively, 1.5% of Chill Brands Group shares are owned by institutional investors. 21.9% of Hikma Pharmaceuticals shares are owned by insiders. Comparatively, 10.3% of Chill Brands Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Hikma Pharmaceuticals has a net margin of 12.00% compared to Chill Brands Group's net margin of 0.00%. Hikma Pharmaceuticals' return on equity of 15.83% beat Chill Brands Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Hikma Pharmaceuticals12.00% 15.83% 9.40%
Chill Brands Group N/A -2,802.21%-44.64%

Hikma Pharmaceuticals has higher revenue and earnings than Chill Brands Group. Chill Brands Group is trading at a lower price-to-earnings ratio than Hikma Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hikma Pharmaceuticals£3.35B0.98£353.21M£181.008.58
Chill Brands Group£305.70K3.51-£3.64M-£6.50N/A

Summary

Hikma Pharmaceuticals beats Chill Brands Group on 14 of the 16 factors compared between the two stocks.

How does Chill Brands Group compare to Indivior?

Chill Brands Group (LON:CHLL) and Indivior (LON:INDV) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, risk, institutional ownership, valuation, media sentiment, dividends, analyst recommendations and earnings.

Indivior has higher revenue and earnings than Chill Brands Group. Indivior is trading at a lower price-to-earnings ratio than Chill Brands Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Chill Brands Group£305.70K3.51-£3.64M-£6.50N/A
Indivior£1.40B1.38-£2.36M-£1.21N/A

Indivior has a net margin of 11.44% compared to Chill Brands Group's net margin of 0.00%. Indivior's return on equity of -23.90% beat Chill Brands Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Chill Brands GroupN/A -2,802.21% -44.64%
Indivior 11.44%-23.90%2.37%

1.5% of Chill Brands Group shares are held by institutional investors. Comparatively, 86.0% of Indivior shares are held by institutional investors. 10.3% of Chill Brands Group shares are held by company insiders. Comparatively, 3.4% of Indivior shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Chill Brands Group has a beta of 0.99, meaning that its share price is 1% less volatile than the broader market. Comparatively, Indivior has a beta of 0.19, meaning that its share price is 81% less volatile than the broader market.

In the previous week, Chill Brands Group's average media sentiment score of 0.00 equaled Indivior'saverage media sentiment score.

Company Overall Sentiment
Chill Brands Group Neutral
Indivior Neutral

Summary

Indivior beats Chill Brands Group on 7 of the 11 factors compared between the two stocks.

How does Chill Brands Group compare to HUTCHMED?

Chill Brands Group (LON:CHLL) and HUTCHMED (LON:HCM) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, institutional ownership, analyst recommendations, risk, profitability and earnings.

Chill Brands Group has a beta of 0.99, indicating that its stock price is 1% less volatile than the broader market. Comparatively, HUTCHMED has a beta of 0.428, indicating that its stock price is 57% less volatile than the broader market.

In the previous week, Chill Brands Group's average media sentiment score of 0.00 equaled HUTCHMED'saverage media sentiment score.

Company Overall Sentiment
Chill Brands Group Neutral
HUTCHMED Neutral

HUTCHMED has a net margin of 163.84% compared to Chill Brands Group's net margin of 0.00%. HUTCHMED's return on equity of 36.88% beat Chill Brands Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Chill Brands GroupN/A -2,802.21% -44.64%
HUTCHMED 163.84%36.88%-5.90%

1.5% of Chill Brands Group shares are owned by institutional investors. Comparatively, 20.4% of HUTCHMED shares are owned by institutional investors. 10.3% of Chill Brands Group shares are owned by company insiders. Comparatively, 2.8% of HUTCHMED shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Chill Brands Group has higher earnings, but lower revenue than HUTCHMED. Chill Brands Group is trading at a lower price-to-earnings ratio than HUTCHMED, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Chill Brands Group£305.70K3.51-£3.64M-£6.50N/A
HUTCHMED£548.51M2.74-£52.98M£53.003.30

Summary

HUTCHMED beats Chill Brands Group on 7 of the 11 factors compared between the two stocks.

Get Chill Brands Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for CHLL and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CHLL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CHLL vs. The Competition

MetricChill Brands GroupDrug Manufacturers IndustryMedical SectorLON Exchange
Market Cap£1.07M£5.83B£6.96B£2.78B
Dividend YieldN/A2.82%2.68%6.12%
P/E Ratio-0.325.0527.20368.15
Price / Sales3.511,648.51578.2684,722.19
Price / Cash11.5010.1849.2527.89
Price / BookN/A10.3710.737.49
Net Income-£3.64M£20.27B£3.59B£5.89B
7 Day Performance2.50%-0.25%-1.95%0.03%
1 Month Performance-20.23%-0.40%2.19%-1.36%
1 Year PerformanceN/A7.80%23.80%62.04%

Chill Brands Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CHLL
Chill Brands Group
N/AGBX 2.05
-6.8%
N/AN/A£1.07M£305.70KN/A7
HELD
Hellenic Dynamics
N/AGBX 0.01
-98.9%
N/AN/A£14KN/AN/AN/A
HLN
Haleon
2.5341 of 5 stars
GBX 358.50
-1.6%
GBX 393.67
+9.8%
+2.8%£31.72B£11.03B19.3825,408
HIK
Hikma Pharmaceuticals
3.1638 of 5 stars
GBX 1,553.89
+0.4%
GBX 1,687
+8.6%
-24.0%£3.30B£3.35B8.599,100
INDV
Indivior
N/AGBX 1,238
+1.6%
N/A+8.5%£1.93B£1.40BN/A1,000

Related Companies and Tools


This page (LON:CHLL) was last updated on 7/17/2026 by MarketBeat.com Staff.
From Our Partners